2005Journal of Bengbu Medical CollegeRequires access

Oxaliplatin in combination with calcium folinate and fluorouracil for treatment of advanced gastric cancer

Zheng Rong-sheng

Open publisher page 0 citations

Abstract

Objective:To evaluate the effect and safety of oxaliplatin(OXA) combined with calcium folinate(CF) and fluorouracil(5-Fu) regimen for patients with advanced gastric cancer.Methods:OXA 130 mg/m~2 (2 hours infusion on the first day),CF 200 mg/m~2 (1 hour infusion for 5 days) and 5-Fu 350 mg/m~2(4 hours infusion on the first day) were administered and the regimen was repeated every 3 weeks.The efficacy was evaluated after two repeated cycles were completed.Results:Twenty-eight patients were included in the study.One patient achieved CR,11 PR,10 SD and 6 PD.The overall response rate was 42.9%.The main adverse effects were bone marrow suppression,nausea,vomiting and neurosensory toxicity.Conclusions:OXA-CF-5-Fu regimen is highly effective for treatment of advanced gastric cancer with mild toxicity.

About this research paper

What this paper is about

Objective:To evaluate the effect and safety of oxaliplatin(OXA) combined with calcium folinate(CF) and fluorouracil(5-Fu) regimen for patients with advanced gastric cancer.Methods:OXA 130 mg/m~2 (2 hours infusion on the first day),CF 200 mg/m~2 (1 hour infusion for 5 days) and 5-Fu 350 mg/m~2(4 hours infusion on the first day) were administered and the regimen was repeated every 3 weeks.The efficacy was evaluated after two repeated cycles were completed.Results:Twenty-eight patients were included in the study.One patient achieved CR,11 PR,10 SD and 6 PD.The overall response rate was 42.9%.The main adverse effects were bone marrow suppression,nausea,vomiting and neurosensory toxicity.Conclusions:OXA-CF-5-Fu regimen is highly effective for treatment of advanced gastric cancer with mild toxicity.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the effect and safety of oxaliplatin(OXA) combined with calcium folinate(CF) and fluorouracil(5-Fu) regimen for patients with advanced gastric cancer.Methods:OXA 130 mg/m~2 (2 hours infusion on the first day),CF 200 mg/m~2 (1 hour infusion for 5 days) and 5-Fu 350 mg/m~2(4 hours infusion on the first day) were administered and the regimen was repeated every 3 weeks.The efficacy was evaluated after two repeated cycles were completed.Results:Twenty-eight patients were included in the study.One patient achieved CR,11 PR,10 SD and 6 PD.The overall response rate was 42.9%.The main adverse effects were bone marrow suppression,nausea,vomiting and neurosensory toxicity.Conclusions:OXA-CF-5-Fu regimen is highly effective for treatment of advanced gastric cancer with mild toxicity.

Key concepts: Medicine, Oxaliplatin, Regimen, Nausea, Vomiting, Fluorouracil, Bone marrow suppression, Toxicity

Related papers

Back to paper searchBrowse research topicsOriginal source
Oxaliplatin in combination with calcium folinate and fluorouracil for treatment of advanced gastric cancer — Research Paper | ScholarLens